AIgnosis Shark Tank India Episode Review
Website Information
- Website:- AIgnosis
- Build on JavaScript frameworks React, React Router & GSAP
- Advertise with Google Ads.
- Poor SEO Performance, SEO improvement is needed.
- ORGANIC TRAFFIC: 0 visitors per month.
Founder
- The founders of AIGnosis are Raksheet Jain, aged 26, and Divyansh Mangal, aged 22.
- Both hail from Jaipur and are passionate about leveraging AI technology to create a positive social impact.
- Raksheet holds a B.Tech in AI, while Divyansh has conducted research in Europe on artificial intelligence and quantum theory after his studies at BITS Pilani.
- Their shared vision led them to establish AIGnosis upon Divyansh’s return to India.

Brand Overview
- AIGnosis is an innovative startup focused on utilizing artificial intelligence to detect autism in children, provide expert consultations, and offer therapeutic solutions.
- AIGnosis specializes in providing AI-powered tools that help parents identify signs of autism and other neurodevelopmental concerns from the comfort of their homes.
- The startup emphasizes accuracy and reliability while maintaining a non-invasive approach to screening.
Shark Tank India Appearance & Ask
- AIGnosis made its debut on Shark Tank India Season 4, where the founders sought an investment of ₹50 lakh for 4% equity, valuing the company at ₹12.5 crore.
- The pitch highlighted the urgency of early autism detection, noting that symptoms can appear as early as age two.
Season and Episode Air Date
- Season: 04
- Episode: 14
- Episode Air Date: Thursday, 23 January 2025
Product Overview
- AIGnosis offers a cost-effective test priced at ₹700 that generates results within just five minutes.
- The product is equipped with 17 AI-powered features designed to analyze data and produce detailed reports regarding a child’s developmental status.
Investor Reactions
- The sharks expressed mixed feelings about the business model but praised the founders’ dedication to tackling autism.
- While some investors raised concerns about the pricing structure and feasibility of their approach, others recognized the potential impact of AIGnosis on early autism detection.
Customer Engagement Philosophy
- AIGnosis aims to engage customers through accessible and affordable screening tools, allowing families to identify developmental issues without invasive procedures.
- The startup also plans to provide professional consultations alongside their testing services, enhancing overall support for families.
Product Highlights
- Price: ₹700 per test
- Time: Results generated within 5 minutes
- Technology: Features 17 AI-powered capabilities for comprehensive analysis
- Business Model: Currently pre-revenue, focusing on partnerships with 250 centers where doctors will review reports and develop treatment plans based on findings.
Future Vision
- The founders envision expanding AIGnosis’s diagnostic capabilities while enhancing their AI algorithms.
- They aim to build research partnerships and develop global solutions that create a comprehensive support ecosystem for children with autism and their families.
- This vision reflects their commitment to making autism detection more accessible and effective across India.
Deal Finalized or Not
- The founders successfully secured a deal with investors Aman Gupta, Varun Dua, and Peyush Bansal, who collectively offered ₹1 crore for 8% equity, maintaining the same valuation of ₹12.5 crore.
- This agreement marked a significant milestone for AIGnosis in its mission to revolutionize autism detection and therapy.

Category | Details |
---|---|
Website Information | |
Website | AIGnosis |
Built On | JavaScript frameworks: React, React Router & GSAP |
Advertising | Google Ads |
SEO Performance | Poor; improvement needed |
Organic Traffic | 0 visitors per month |
Founders | |
Names | Raksheet Jain (26), Divyansh Mangal (22) |
Background | Raksheet: B.Tech in AI; Divyansh: Research in AI & Quantum Theory (BITS Pilani, Europe) |
Origin | Both hail from Jaipur, India |
Vision | Leveraging AI to create positive social impact through autism detection and therapy |
Brand Overview | |
Focus | AI-powered tools for early autism detection, expert consultations, and therapeutic solutions |
Specialty | Non-invasive, home-based autism screening |
Emphasis | Accuracy, reliability, and affordability |
Shark Tank India Appearance | |
Season | 04 |
Episode | 14 |
Air Date | Thursday, 23 January 2025 |
Ask | ₹50 lakh for 4% equity (₹12.5 crore valuation) |
Deal Finalized | ₹1 crore for 8% equity (₹12.5 crore valuation) |
Investors | Aman Gupta, Varun Dua, and Peyush Bansal |
Product Overview | |
Product | Autism screening tool |
Price | ₹700 per test |
Time | Results in 5 minutes |
Technology | 17 AI-powered features for comprehensive analysis |
Business Model | Pre-revenue, focusing on partnerships with 250 centers for report reviews and treatment plans |
Investor Reactions | |
Positive Feedback | Praised the founders’ dedication to addressing autism |
Concerns | Pricing structure and feasibility of scaling |
Customer Engagement Philosophy | |
Accessibility | Affordable and non-invasive screening for parents |
Support | Plans to integrate professional consultations along with test results |
Business Potential in India | |
Market Overview | Indian diagnostics market valued at $13B (2023), projected to double by 2028 |
AI in Diagnostics | $41M (2023), projected to reach $225.9M by 2030 (CAGR: 27.6%) |
Government Support | National Health Stack and AI Portal initiatives |
TAM (Total Addressable Market) | AI diagnostics: $0.24B by 2030 (CAGR: 38%) |
Target Audience & Demographics | |
Primary Audience | Parents of children aged 2–10 years |
Demographics | Age: 25–40; Urban areas; Middle to upper-middle class |
Marketing Strategy | |
Content Marketing | Educational content about autism awareness and early detection |
Digital Marketing | Google Ads, social media campaigns (Facebook, Instagram), testimonials |
Distribution Strategy | Partnerships with healthcare centers and pediatricians; online direct-to-consumer sales |
Advantages | |
Technology | Non-invasive, AI-driven early autism detection |
Cost-effectiveness | Affordable pricing at ₹700 per test |
Challenges | |
Competition | Competing with established diagnostics companies and emerging startups |
SEO Performance | Poor organic traffic requires focused SEO improvements |
Reasons for Success | |
Awareness | Growing parental awareness of autism and early detection importance |
Supportive Environment | Strong government backing for AI in healthcare |
Mitigation Strategies | |
SEO Optimization | Focused efforts to improve visibility and traffic |
User Feedback | Gather insights for continuous improvement of offerings |
Future Business Roadmap | |
Short-term (1 year) | Improve SEO; partner with 250+ healthcare centers |
Medium-term (2–3 years) | Expand to additional neurodevelopmental screenings; launch mobile app |
Long-term (5 years) | Scale operations nationally and explore global markets |
AIGnosis Shark Tank India Business Plan

Business Potential in India
- Market Overview: The Indian diagnostics market was valued at approximately $13 billion in 2023 and is expected to grow significantly, potentially doubling by 2028.
- AI in Diagnostics Growth: The AI diagnostics market in India generated $41 million in 2023 and is projected to reach $225.9 million by 2030, with a CAGR of 27.6%.
- Government Support: Initiatives like the National Health Stack program and the National AI Portal are promoting AI in healthcare, indicating strong governmental backing for startups like AIGnosis.
Total Addressable Market (TAM)
- The AI diagnostics market is expected to grow from $0.02 billion in 2022 to $0.24 billion by 2030, reflecting a CAGR of 38%.
- The overall diagnostics market is projected to reach $7.8 billion by 2030, growing at a CAGR of 19.9%.
Ideal Target Audience and Demographics
- Primary Audience: Parents of children aged 2-10 years who are concerned about developmental issues.
- Demographics:
- Age: 25-40 years
- Location: Urban areas with access to digital tools
- Socioeconomic Status: Middle to upper-middle class, typically with higher education levels.
Marketing Strategy
- Content Marketing: Develop educational content around autism awareness, early detection, and the importance of timely intervention.
- Digital Marketing Strategy:
- Utilize Google Ads targeting parents searching for developmental screening.
- Leverage social media platforms (Facebook, Instagram) to reach parents through engaging posts and testimonials.
Distribution Strategy
- Partner with healthcare centers and pediatricians for referrals.
- Utilize online platforms for direct-to-consumer sales of testing kits.
Advantages
- Innovative Technology: AIGnosis offers a non-invasive, AI-driven solution for early autism detection.
- Cost-effective Testing: Priced at ₹700, making it accessible for many families.
Challenges
- Market Competition: Competing against established diagnostic companies and emerging startups.
- SEO Performance: Currently poor organic traffic necessitates a strong SEO strategy to improve visibility.
Reasons for Success
- Growing awareness of autism and the importance of early detection among parents.
- Strong government support for AI in healthcare, creating a conducive environment for growth.
Mitigation Strategies
- Enhance SEO efforts to increase organic traffic and visibility.
- Regularly gather user feedback to improve product offerings and customer satisfaction.
Future Business Roadmap
Short-term (1 year):
- Improve SEO performance to increase organic traffic.
- Establish partnerships with over 250 healthcare centers.
Medium-term (2-3 years):
- Expand product offerings to include additional neurodevelopmental screenings.
- Develop mobile applications for easier access and user engagement.
Long-term (5 years):
- Scale operations nationally and explore international markets.
- Aim for continuous improvement of AI algorithms based on user data.
By focusing on these strategic areas, AIGnosis can enhance its market presence, improve its service offerings, and ultimately increase its valuation as it aims to revolutionize autism detection in India.